India’s fastest growing comprehensive diagnostics powerhouse opens its first integrated pathology, radiology & cardiology centre in Gurugram — with a 50-centre, ₹250 crore mission to make world-class, coordinated diagnostics accessible and affordable in the country’s fringe and Tier 2/3 cities.
Gurugram (Haryana) [India], August 1: TRUtest Diagnostics, incubated by the Manipal Group, has launched its first integrated pathology, radiology and cardiology centre — and with it, a nationwide mission to make world-class, coordinated diagnostics accessible and affordable well beyond India’s metros. The company will build 50 such centres over the next five years, with the sharpest focus on the fringe and Tier 2/3 cities where 68% of India’s urban population lives and 40-45% of India’s GDP is already generated — yet fewer than 30% of diagnostic centres nationally offer truly integrated care. TRUtest is entering this gap with zero compromise on quality: the same NABL/NABH-accredited, scale-proven standards that have already served over 1.30 crore patients across 100+ centres and 18 states.
It is a declaration of intent: India’s next chapter in healthcare will not be written only in its metros, but in every pin code the country has to offer — and it starts with honest affordable pricing, a family-first membership model, doctor-explained reports, and a promise that quality diagnostics should never be a metro-only privilege.
| 50 integrated centres planned nationally in 5 years | Rs 250 Cr in the fringe & Tier 2/3 | 68% of India’s urban population lives in Tier 2 & 3 cities |
Stepping into the centre in Gurgaon Fringes feels less like a clinical errand and more like stepping into a calm, considered space engineered to put people at ease long before the scan begins. It is diagnostics reimagined as an experience of care, not a transaction — and it is designed to travel to exactly the cities that have never had access to it.
Affordability and Accessibility, Engineered
Years spent running high-volume public-private partnership and institutional diagnostic operations across entire districts and states have taught the company how to deliver uncompromising quality at radically lower cost. That scale advantage is now being passed directly to the consumer — honest, transparent pricing with zero compromise on quality or turnaround time, built for markets that have long been priced out of branded, integrated diagnostics.
Every new TRUtest centre also becomes a local growth engine — creating jobs for technicians, phlebotomists, radiologists and support staff on the ground, while lifting local vendors, transport and allied services in the neighbourhoods it serves. This is not diagnostics arriving from outside a city; it is diagnostics built into the local economy.
Not Just a New Brand — A New Category of Care
TRUtest is entering the market with a suite of concrete, live innovations designed to move diagnostics beyond a one-time report and into a lifelong health relationship:
- Honest & Transparent Pricing — high-quality diagnostics at substantially lower rates than the market, with zero compromise on quality or turnaround time as we have acquired the knowledge & expertise of economies of scale in the ongoing PPP & B2B businesses serving the masses.
- TRU-Mitra Family Plan — one family, one membership, one relationship manager — a loyalty programme built around continuous care, not a one-off visit.
- Smart Reporting & Report Counselling — every report interpreted and explained by a doctor, with a complimentary consultation, turning results into actionable health insight.
- Genomic & Metabolic Integrated Panels — predisposition testing and metabolic deep-dives, combined with radiology, extending well beyond routine testing.
- Elderly & Chronic Care Reminders — a predictive Annual Health Calendar with proactive concierge check-ins, so a good report is never followed by silence.
- ABHA-Integrated Reporting & Low-Dose CT Screening — reports woven into India’s national digital health record, alongside advanced early-detection scanning for lung and cardiac risk.
Leadership Commentary
“We are India’s fastest-growing comprehensive diagnostics company — and that growth is built on the ethos and legacy of the Manipal Group, a heritage that has always put trust, accuracy and hygiene first.”
“But we believe trust today needs a new lens. India’s healthcare story for the last two decades has been about building capacity — more hospitals, more beds, more labs. The next two decades will be about building trust at the individual level. And for us, that trust isn’t only a promise — it’s tangible innovation: transforming what it actually feels like to get tested and turning every result into a step in someone’s journey toward longevity and wellness, not just a report filed away.”
— Dr. (Capt.) Sandeep Sharma, CEO, Healthmap Diagnostics Pvt. Ltd.
The Road Ahead: 50 Centres, ₹250 Crore, Five Years
With its first integrated centre now live in Gurugram, TRUtest Diagnostics will roll out four more centres across the Delhi-NCR region in FY26-27, before expanding into the fringe and Tier 2/3 cities that sit at the heart of its mission. Over the next five years, the company plans to build 50 such centres nationally, targeting an overall revenue of ₹250 crore by Year 5 — the same proven PPP and institutional economics that built its scale, now aimed squarely at the cities growing fastest.
TRUtest Diagnostics is not setting out merely to deliver accurate results. It is setting out to build India’s most trusted, most accessible, end-to-end diagnostics experience — one that gives every individual, in every pin code, timely insight, a simplified path to care, and greater confidence in managing their health, for life.
Built Different, From Day One
India’s diagnostics industry remains strikingly unorganised — listed players together account for barely 10-12% of the market — and even among organised players, most operate lopsided, heavy in either pathology or radiology, rarely both. TRUtest was conceived to break that mould: built from day one on an equal, 50:50 foundation of pathology and radiology, because accurate diagnosis cannot be delivered in isolated fragments.
Built Through Scale and Consolidation
HealthMap Diagnostics began its journey through public-private partnership (PPP) initiatives across Haryana and Jharkhand before expanding organically into pathology and radiology as distinct business verticals. The company’s growth accelerated through the strategic acquisitions of Medcis Pathlabs, strengthening its routine pathology capabilities, and iGenetic, enhancing its specialty diagnostics portfolio. These milestones culminated in an NCLT-approved merger in 2023, alongside a significant expansion of its PPP footprint in Maharashtra. Today, HealthMap Diagnostics has established a strong presence across Haryana, Jharkhand, Karnataka, Maharashtra, Tamil Nadu and Odisha.
Scale, Trust and Recognition
| 100+ locations across 18 states | NABL / NABH-accredited centres | 3,500+ tests & scans on the menu | 1.3 Cr+ patients served to date |
The company has been recognised as the Most Renowned Diagnostic Chain in India (2024) and the Most Trusted Diagnostic Chain in India (2023), alongside FICCI and India Today Excellence in Healthcare honours (2018) and Express Healthcare’s Best Radiology Chain award (2018 and 2019).
If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.
